CARLOS
OCHOA SANGRADOR
Researcher in the period 2019-2022
![Foto de CARLOS](/img/uploaded/4864c788233f23b801fb175de837cdb3.jpg)
![Foto de University Hospital of Zurich](/img/noimage_org.png)
University Hospital of Zurich
Zúrich, SuizaPublications in collaboration with researchers from University Hospital of Zurich (1)
2022
-
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
Genetics in Medicine, Vol. 24, Núm. 8, pp. 1781-1788